Related references
Note: Only part of the references are listed.Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma
Pramod Mallikarjuna et al.
CELL CYCLE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway
Tianfeng Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anticancer potential of sanguinarine for various human malignancies
Iman W. Achkar et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study
Rosina Critelli et al.
CELL DEATH & DISEASE (2017)
HIF-1 in cancer therapy: two decade long story of a transcription factor
Sourabh Soni et al.
ACTA ONCOLOGICA (2017)
Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer
Mary Topalovski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli et al.
JOURNAL OF HEPATOLOGY (2016)
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du et al.
MOLECULES (2016)
Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives
Roberta Gaziano et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Transforming growth factor-β signaling enhancement by long-term exposure to hypoxia in a tumor microenvironment composed of Lewis lung carcinoma cells
Chiaki Furuta et al.
CANCER SCIENCE (2015)
High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
Tzu-Hsuan Lin et al.
CLINICAL CANCER RESEARCH (2015)
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Panagiotis Papageorgis
JOURNAL OF ONCOLOGY (2015)
Epithelial to Mesenchymal Transition in a Clinical Perspective
Jennifer Pasquier et al.
JOURNAL OF ONCOLOGY (2015)
Molecular Pathways: Linking Tumor Microenvironment to Epithelial-Mesenchymal Transition in Metastasis
Hae-Yun Jung et al.
CLINICAL CANCER RESEARCH (2015)
Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response
S. R. McKeown
BRITISH JOURNAL OF RADIOLOGY (2014)
Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC
Xiaolu Zhai et al.
MEDICAL ONCOLOGY (2014)
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
Motoyuki Hashiguchi et al.
BMC CANCER (2013)
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1α in hepatocellular carcinoma
Lin Zhang et al.
BMC CANCER (2013)
Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
Junko Matsuoka et al.
PLOS ONE (2013)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
Kian-Ngiap Chua et al.
PLOS ONE (2012)
Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma
Helene Marijon et al.
JOURNAL OF HEPATOLOGY (2011)
Epithelial-mesenchymal transition in hepatocellular carcinoma
Franziska van Zijl et al.
FUTURE ONCOLOGY (2009)
Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine- promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA
Isabel Molina-Ortiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice
Lorea Bueno et al.
EUROPEAN JOURNAL OF CANCER (2008)
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
Emilia Fransvea et al.
HEPATOLOGY (2008)
Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma
Sung Bum Cho et al.
PATHOLOGY INTERNATIONAL (2008)
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Barbara A. Frederick et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Transforming growth factor β1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression
Stephanie McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines
SE Witta et al.
CANCER RESEARCH (2006)
Share Paper
